Cadence

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Canaccord Adams Global Growth Conference in Boston on August 11, 2009

... SAN DIEGO, Aug. 4 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biophar...l be simultaneously webcast and can be accessed on cadence Pharmaceuticals' website at www.cadencepharm.com i...st and will be archived for 90 days. About cadence Pharmaceuticals, Inc. ...

St. Elizabeth Healthcare Drives Kentucky's Largest Electronic Medical Records Initiative With IBM

... medical records and clinical information system includes EpicCare Ambulatory, Resolute Hospital Billing, EpicCare Inpatient, Prelude Registration and cadence Scheduling. IBM Power Systems servers with virtualization technology provide the advanced computing power to support the system, and offer th...

Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance(TM) for Treatment of Acute Pain and Fever

... SAN DIEGO, July 15 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ) announced...tes. About Acetavance Acetavance is cadence Pharmaceuticals' proprietary intravenous formulati...edient prescription and over-the-counter products. cadence acquired the exclusive rights to Acetavance in the...

Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer

... SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ) announced ...keting, and supply operations. Mr. Byrd joins cadence from Eli Lilly and Company (Lilly) where he held p...ence with prasugrel will be a significant asset to cadence as we prepare to commercialize Acetavance(TM), for...

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009

... SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biophar...l be simultaneously webcast and can be accessed on cadence Pharmaceuticals' website at www.cadencepharm.com ...cast and will be archived for 90 days. About cadence Pharmaceuticals, Inc. ...

Medical Facilities Among Finalists for Greater Dallas Business Ethics Awards

...Center, L.L.P., were among the nine finalists. The other 2009 finalists were: Altair Global Relocation, American Fuel Distributors, L.P., Aspire, cadence McShane Construction Company and The Dwyer Group. Balfour Beatty Construction was honored in the mid-sized category. Sleep Experts was honored in the ...

Hill-Rom Reports Second Quarter Financial Results

...vering growth at or above market in most of our units. Our balance sheet is healthy, cash flow increased both sequentially and year-over-year and the cadence of new product introduction continues to improve." Other second quarter revenue highlights regarding Hill-Rom business segments include: --...

Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009

...AN DIEGO , April 30 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biophar... the market closes on Thursday, May 7, 2009. cadence management will host a conference call and live we...next quarterly financial results call. About cadence Pharmaceuticals, Inc. ...

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at Cowen & Company's 29th Annual Health Care Conference in Boston on March 16, 2009

... SAN DIEGO, March 9 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biophar...l be simultaneously webcast and can be accessed on cadence Pharmaceuticals' website at www.cadencepharm.com ...cast and will be archived for 90 days. About cadence Pharmaceuticals, Inc. ...

Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock

... SAN DIEGO, Feb. 19 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ) announced ...the securities laws of any such state. About cadence Pharmaceuticals, Inc. cadence Pharmaceuticals is a biopharmaceutical company foc...

Cadence in Medical Technology

Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever

... SAN DIEGO, May 14 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ) announced ...ion of the Acetavance NDA is a major milestone for cadence and demonstrates our commitment to develop product...ries outside the United States. Acetavance is cadence Pharmaceuticals' proprietary intravenous formulati...

Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update

... SAN DIEGO, Nov. 6 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharm...." In addition, during the third quarter of 2008 cadence completed patient enrollment in its clinical trial...Financial Results For the third quarter of 2008, cadence reported a net loss of $13.7 million, or $0.36 per...

Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline

... SAN DIEGO, Sept. 15 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ) announced t...r the prevention of catheter-related infections. cadence is currently engaged in discussions with the U.S. ...o unblinding the data from the trial. As a result, cadence has revised the expected timing of its announcemen...

Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008

... SAN DIEGO, July 28 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharm...re the market opens on Thursday, August 7, 2008. cadence management will host a conference call and live we...the next quarterly financial results call. About cadence Pharmaceuticals, Inc. ...

Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update

...lment SAN DIEGO, May 6 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharm...fever compared to oral acetaminophen. In addition, cadence announced that it completed its goal of enrolling ...ults For the first quarter ended March 31, 2008, cadence reported a net loss of $13.7 million, or $0.42 per...

Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule

... SAN DIEGO, Aug. 30 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharm...from this trial may be available in 2008; however, cadence does not plan to rely on this clinical trial as a ...ated with significant adverse side effects. About cadence Pharmaceuticals, Inc. ...

Cadence in Medical Products

Cadence

Features:... cadence Ti provides another innovative solution to surgeons who prefer the strength of titanium. cadence Ti is engineered to meet the demands of surgery while maintaining simplicit...
Company:Abbott Spine

Cadence in Biological News

Mental fatigue can affect physical endurance

... participants did an intense bout of exercise on a stationary bicycle. They rode until exhaustion, defined as the point when they could not maintain a cadence of at least 60 revolutions per minute for more than five seconds. Throughout both exercise sessions, the researchers tracked a variety of physiolog...

Lance Armstrong through a physiological lens: hard training boosts muscle power 8%

...rison purposes, Armstrong's "freely chosen cycling cadence during time trial races of 30- to 60-minute durati...rcentage of type I fibers choose a higher pedaling cadence when exercising at high power outputs," the report...his may initially seem paradoxical, higher cycling cadence serves to both bring muscle fiber contraction velo...

Cadence in Biological Technology

Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

... SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biophar...0, 2009. During the second quarter of 2009, cadence submitted its New Drug Application (NDA) for Aceta...." Also during the second quarter of 2009, cadence announced that Scott Byrd joined the company as Se...

Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results

... SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biophar... 2009," stated Ted Schroeder, President and CEO of cadence Pharmaceuticals. "We also achieved another importa...nce, if approved by the FDA." In March 2009, cadence announced that its Phase III clinical trial of Omi...

Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Two Investment Conferences During the Month of May 2009

... SAN DIEGO, May 5 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biophar...l be simultaneously webcast and can be accessed on cadence Pharmaceuticals' website at www.cadencepharm.com ...and will remain available for 30 days. About cadence Pharmaceuticals, Inc. ...

Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences

... SAN DIEGO, April 27 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ) announced ...udy 352, which was recently completed. About cadence Pharmaceuticals, Inc. cadence Pharmaceuticals is a biopharmaceutical company foc...

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference in New York on April 2, 2009

... SAN DIEGO, March 26 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biophar...l be simultaneously webcast and can be accessed on cadence Pharmaceuticals' website at www.cadencepharm.com ...cast and will be archived for 90 days. About cadence Pharmaceuticals, Inc. ...

Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2008 Financial Results and Corporate Update on March 12, 2009

... SAN DIEGO, March 5 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biophar...e market closes on Thursday, March 12, 2009. cadence management will host a conference call and live we...next quarterly financial results call. About cadence Pharmaceuticals, Inc. ...

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference

... SAN DIEGO, Feb. 10 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biophar...l be simultaneously webcast and can be accessed on cadence Pharmaceuticals' website at www.cadencepharm.com ...cast and will be archived for 90 days. About cadence Pharmaceuticals, Inc. ...

Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and Provide a Clinical Program Update on November 6, 2008

... SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharm...the market closes on Thursday, November 6, 2008. cadence management will host a conference call and live we...the next quarterly financial results call. About cadence Pharmaceuticals, Inc. ...

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the BIOCOM Investor Conference

... SAN DIEGO, Oct. 21 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharm... webcast and will be archived for 30 days. About cadence Pharmaceuticals, Inc. cadence Pharmaceuticals is a biopharmaceutical company foc...

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference

... SAN DIEGO, Sept. 29 /PRNewswire-FirstCall/ -- cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharm... webcast and will be archived for 90 days. About cadence Pharmaceuticals, Inc. cadence Pharmaceuticals is a biopharmaceutical company foc...